274 related articles for article (PubMed ID: 7782188)
1. Comparison of gadolinium Cy2DOTA, a new hepatobiliary agent, and gadolinium HP-DO3A, an extracellular agent, in healthy liver and metastatic disease.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1995 Feb; 30(2):123-30. PubMed ID: 7782188
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360
[TBL] [Abstract][Full Text] [Related]
3. Detectability of small liver metastases with gadolinium BOPTA.
Runge VM; Lee C; Williams NM
Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044
[TBL] [Abstract][Full Text] [Related]
4. Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1996 Dec; 31(12):781-8. PubMed ID: 8970881
[TBL] [Abstract][Full Text] [Related]
5. Early dynamic magnetic resonance imaging of liver metastases with 0.3 and 0.6 mmol/kg gadoteridol injection.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1996 Aug; 31(8):472-8. PubMed ID: 8854193
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of standard and high-dose contrast-enhanced breath-hold liver magnetic resonance for visualization of metastatic disease in an animal model.
Runge VM
Invest Radiol; 1998 May; 33(5):263-7. PubMed ID: 9609484
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and imaging performance of a new class of macrocyclic hepatobiliary MR contrast agents.
Marinelli ER; Neubeck R; Song B; Wagler T; Ranganathan RS; Sukumaran K; Wedeking PW; Nunn A; Runge VM; Tweedle MF
Invest Radiol; 2000 Jan; 35(1):8-24. PubMed ID: 10639032
[TBL] [Abstract][Full Text] [Related]
8. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA.
Runge VM
J Comput Assist Tomogr; 1998; 22(4):643-50. PubMed ID: 9676461
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced magnetic resonance imaging in a spinal epidural tumor model.
Runge VM; Lee C; Iten AL; Williams NM
Invest Radiol; 1997 Oct; 32(10):589-95. PubMed ID: 9342117
[TBL] [Abstract][Full Text] [Related]
10. Renal metastasis. Detection and characterization on enhanced magnetic resonance imaging using an animal model.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1997 Apr; 32(4):212-7. PubMed ID: 9101356
[TBL] [Abstract][Full Text] [Related]
11. Choice of metal ion and formulation concentration for first-pass brain perfusion studies with magnetic resonance imaging at 1.5 tesla.
Runge VM; Wells JW
Invest Radiol; 1996 Jul; 31(7):395-400. PubMed ID: 8818779
[TBL] [Abstract][Full Text] [Related]
12. Magnetization transfer and high-dose contrast in early brain infection on magnetic resonance.
Runge VM; Wells JW; Kirsch JE
Invest Radiol; 1995 Mar; 30(3):135-43. PubMed ID: 7797410
[TBL] [Abstract][Full Text] [Related]
13. Detectability of early brain meningitis with magnetic resonance imaging.
Runge VM; Wells JW; Williams NM; Lee C; Timoney JF; Young AB
Invest Radiol; 1995 Aug; 30(8):484-95. PubMed ID: 8557515
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of experimental pyelonephritis in rabbits.
Runge VM; Timoney JF; Williams NM
Invest Radiol; 1997 Nov; 32(11):696-704. PubMed ID: 9387058
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging of an experimental model of intracranial metastatic disease. A study of lesion detectability.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1994 Dec; 29(12):1050-6. PubMed ID: 7721546
[TBL] [Abstract][Full Text] [Related]
16. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
[TBL] [Abstract][Full Text] [Related]
17. High-dose applications of gadolinium chelates in magnetic resonance imaging.
Runge VM; Kirsch JE; Thomas GS
Magn Reson Med; 1991 Dec; 22(2):358-63. PubMed ID: 1812371
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced magnetic resonance imaging in a model of splenic metastasis.
Runge VM; Williams NM
Invest Radiol; 1998 Jan; 33(1):45-50. PubMed ID: 9438509
[TBL] [Abstract][Full Text] [Related]
19. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
20. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG
Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
